Countless surveys have been conducted on the incidence of impotence in men, especially after inexpensive generics were permitted to enter the US, but the one that comes closest to acceptable standards pegs the rate at 40-50%. Ironically, this is the megabucks that the makers of branded and unbranded drugs are trying hard to outrun each other to get.
With this serving as a backdrop, you understand why it is common to get questions such as “is buying cheap generics from an online pharmacy an invitation to danger?” Is there is truth in this allegation over generics? Let’s see. A new molecule, sildenafil citrate, was created by pharmaceutical giant Pfizer to tap the virgin male impotency market, which proved to be an instantly successful move. This mega billion dollar product came to market immediately following the world entering into an era of intellectual property regime which guarantees to protect certain rights of inventors but allows the average guy the ability to buy the new inventions.
Basically, this means that others in the market can “reinvent” some products and sell them openly on the market under strict limitations that include bans on appearing to be representing the original product.
It seems this cuts into the first inventors’ previously untapped market share, which decays quickly as each new retailer provides generics that equal their originals, specification for specification. All products, especially the high end branded drugs, are subject to market dynamics. It is probably naive to blame the manufacturers as the sole perpetrators because you can’t ignore the strong ties between them and other vested interests, such as retailers and the so-called experts who go all out to protect their ‘rights’ from what they call the invasive powers of inexpensive generics being sold by non-US pharmacy websites.
Various competing agencies must license the generics before they can be imported into the US and they are subject to strict verifiable conditions to make them safer. The conditions in which cheap generics can be sold in the United States are laid out by the Food and Drug Authority, a Federal regulatory agency. It is the duty of the agency to make sure that all medications, no matter where they were manufactured, to conform to certain safety, efficacy, shelf life standards, and more. In order to sell a manufactured generic from outside of the USA, a US FDA certificate is required.
If the lobbyists hadn’t made such a big deal out of the cheap generics, I would have laughed at them. This is nothing new and neither they or anyone else in the world for that matter has become comfortable with this, so for the makers of generic drugs, it’s business as usual.